0001645842-22-000013.txt : 20220203 0001645842-22-000013.hdr.sgml : 20220203 20220203181541 ACCESSION NUMBER: 0001645842-22-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220201 FILED AS OF DATE: 20220203 DATE AS OF CHANGE: 20220203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kimball Aaron CENTRAL INDEX KEY: 0001845645 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40354 FILM NUMBER: 22590096 MAIL ADDRESS: STREET 1: 5980 HORTON ST., STE 105 CITY: EMERYVILLE STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zymergen Inc. CENTRAL INDEX KEY: 0001645842 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 462942439 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5980 HORTON STREET, SUITE 105 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (415) 801-8073 MAIL ADDRESS: STREET 1: 5980 HORTON STREET, SUITE 105 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: Zymergen, Inc. DATE OF NAME CHANGE: 20150622 4 1 wf-form4_164393010936470.xml FORM 4 X0306 4 2022-02-01 0 0001645842 Zymergen Inc. ZY 0001845645 Kimball Aaron 5980 HORTON STREET, SUITE 105 EMERYVILLE CA 94608 0 1 0 0 Chief Technology Officer Common Stock 2022-02-01 4 S 0 25000 5.0642 D 770283 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021. Transaction executed in multiple trades at prices ranging from $4.93 to $5.25 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. /s/ Mina Kim, attorney-in-fact 2022-02-03